206 related articles for article (PubMed ID: 22438808)
1. Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine.
Couesnon A; Molgó J; Connan C; Popoff MR
PLoS Pathog; 2012; 8(3):e1002583. PubMed ID: 22438808
[TBL] [Abstract][Full Text] [Related]
2. Translocation and dissemination to target neurons of botulinum neurotoxin type B in the mouse intestinal wall.
Connan C; Varela-Chavez C; Mazuet C; Molgó J; Haustant GM; Disson O; Lecuit M; Vandewalle A; Popoff MR
Cell Microbiol; 2016 Feb; 18(2):282-301. PubMed ID: 26294282
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin type B uses a distinct entry pathway mediated by CDC42 into intestinal cells versus neuronal cells.
Connan C; Voillequin M; Chavez CV; Mazuet C; Leveque C; Vitry S; Vandewalle A; Popoff MR
Cell Microbiol; 2017 Aug; 19(8):. PubMed ID: 28296078
[TBL] [Abstract][Full Text] [Related]
4. Translocation and dissemination of botulinum neurotoxin from the intestinal tract.
Fujinaga Y; Popoff MR
Toxicon; 2018 Jun; 147():13-18. PubMed ID: 29074396
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
6. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
Zhang P; Ray R; Singh BR; Ray P
Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
[TBL] [Abstract][Full Text] [Related]
7. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
8. Intrastriatally injected botulinum neurotoxin-A differently effects cholinergic and dopaminergic fibers in C57BL/6 mice.
Hawlitschka A; Holzmann C; Witt S; Spiewok J; Neumann AM; Schmitt O; Wree A; Antipova V
Brain Res; 2017 Dec; 1676():46-56. PubMed ID: 28919466
[TBL] [Abstract][Full Text] [Related]
9. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
[TBL] [Abstract][Full Text] [Related]
10. Translocation of botulinum neurotoxin serotype A and associated proteins across the intestinal epithelia.
Lam TI; Stanker LH; Lee K; Jin R; Cheng LW
Cell Microbiol; 2015 Aug; 17(8):1133-43. PubMed ID: 25640773
[TBL] [Abstract][Full Text] [Related]
11. Neuronal selectivity of botulinum neurotoxins.
Poulain B; Lemichez E; Popoff MR
Toxicon; 2020 Apr; 178():20-32. PubMed ID: 32094099
[TBL] [Abstract][Full Text] [Related]
12. Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.
Kroken AR; Blum FC; Zuverink M; Barbieri JT
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795365
[TBL] [Abstract][Full Text] [Related]
13. Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.
Harper CB; Martin S; Nguyen TH; Daniels SJ; Lavidis NA; Popoff MR; Hadzic G; Mariana A; Chau N; McCluskey A; Robinson PJ; Meunier FA
J Biol Chem; 2011 Oct; 286(41):35966-35976. PubMed ID: 21832053
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane.
Muraro L; Tosatto S; Motterlini L; Rossetto O; Montecucco C
Biochem Biophys Res Commun; 2009 Feb; 380(1):76-80. PubMed ID: 19161982
[TBL] [Abstract][Full Text] [Related]
15. Recombinant botulinum neurotoxin A heavy chain-based delivery vehicles for neuronal cell targeting.
Ho M; Chang LH; Pires-Alves M; Thyagarajan B; Bloom JE; Gu Z; Aberle KK; Teymorian SA; Bannai Y; Johnson SC; McArdle JJ; Wilson BA
Protein Eng Des Sel; 2011 Mar; 24(3):247-53. PubMed ID: 21051321
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.
Lee K; Lam KH; Kruel AM; Mahrhold S; Perry K; Cheng LW; Rummel A; Jin R
Toxicon; 2015 Dec; 107(Pt A):43-9. PubMed ID: 26272706
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the functional activity of botulinum neurotoxin subtype B6.
Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A.
Brier S; Rasetti-Escargueil C; Wijkhuisen A; Simon S; Marechal M; Lemichez E; Popoff MR
FASEB J; 2021 May; 35(5):e21540. PubMed ID: 33817838
[TBL] [Abstract][Full Text] [Related]
19. 8-Hydroxyquinoline and hydroxamic acid inhibitors of botulinum neurotoxin BoNT/A.
Dickerson TJ; Smith GR; Pelletier JC; Reitz AB
Curr Top Med Chem; 2014; 14(18):2094-102. PubMed ID: 25335884
[TBL] [Abstract][Full Text] [Related]
20. SV2 is the protein receptor for botulinum neurotoxin A.
Dong M; Yeh F; Tepp WH; Dean C; Johnson EA; Janz R; Chapman ER
Science; 2006 Apr; 312(5773):592-6. PubMed ID: 16543415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
